SIRT1 is a regulator of autophagy: Implications for the progression and treatment of myocardial ischemia-reperfusion
Pharmacological Research · 2024-01 · 199 · 106957
DOI: 10.1016/j.phrs.2023.106957 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmacological Research, 2024-01. Verfasst von Xiaoqing Ding und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Exercise and Health, Shanghai University of Sport, Shanghai 200438, China. Hauptthemen laut MEDLINE: Myocardial Reperfusion Injury, Myocardial Ischemia, Coronary Artery Disease. Die Arbeit wurde bisher 176-mal zitiert (Crossref) und nennt 193 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Shanghai University of Sport.
Abstract (Originalsprache)
SIRT1 is a highly conserved nicotinamide adenine dinucleotide (NAD+)-dependent histone deacetylase. It is involved in the regulation of various pathophysiological processes, including cell proliferation, survival, differentiation, autophagy, and oxidative stress. Therapeutic activation of SIRT1 protects the heart and cardiomyocytes from pathology-related stress, particularly myocardial ischemia/reperfusion (I/R). Autophagy is an important metabolic pathway for cell survival during energy or nutrient deficiency, hypoxia, or oxidative stress. Autophagy is a double-edged sword in myocardial I/R injury. The activation of autophagy during the ischemic phase removes excess metabolic waste and helps ensure cardiomyocyte survival, whereas excessive autophagy during reperfusion depletes the cellular components and leads to autophagic cell death. Increasing research on I/R injury has indicated that SIRT1 is involved in the process of autophagy and regulates myocardial I/R. SIRT1 regulates autophagy through various pathways, such as the deacetylation of FOXOs, ATGs, and LC3. Recent studies have confirmed that SIRT1-mediated autophagy plays different roles at different stages of myocardial I/R injury. By targeting the mechanism of SIRT1-mediated autophagy at different stages of I/R injury, new small-molecule drugs, miRNA activators, or blockers can be developed. For example, resveratrol, sevoflurane, quercetin, and melatonin in the ischemic stage, coptisine, curcumin, berberine, and some miRNAs during reperfusion, were involved in regulating the SIRT1-autophagy axis, exerting a cardioprotective effect. Here, we summarize the possible mechanisms of autophagy regulation by SIRT1 in myocardial I/R injury and the related molecular drug applications to identify strategies for treating myocardial I/R injury.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Exercise and Health, Shanghai University of Sport, Shanghai 200438, China.
- School of Athletic Performance, Shanghai University of Sport, Shanghai 200438, China. Electronic address: binghong.gao@hotmail.com.
Förderung
- National Natural Science Foundation of China
- Shanghai University of Sport
Zitieren
APA
Ding, X., Zhu, C., Wang, W., Li, M., Ma, C., & Gao, B. (2024). SIRT1 is a regulator of autophagy: Implications for the progression and treatment of myocardial ischemia-reperfusion. Pharmacological Research, 199, 106957. https://doi.org/10.1016/j.phrs.2023.106957
Vancouver
Ding X, Zhu C, Wang W, Li M, Ma C, Gao B. SIRT1 is a regulator of autophagy: Implications for the progression and treatment of myocardial ischemia-reperfusion. Pharmacological Research. 2024;199:106957. doi:10.1016/j.phrs.2023.106957
BibTeX
@article{Ding2024,
author = {Ding, Xiaoqing and Zhu, Chenyu and Wang, Wenhong and Li, Mengying and Ma, Chunwei and Gao, Binghong},
title = {SIRT1 is a regulator of autophagy: Implications for the progression and treatment of myocardial ischemia-reperfusion},
journal = {Pharmacological Research},
year = {2024},
volume = {199},
pages = {106957},
doi = {10.1016/j.phrs.2023.106957}
}
EUVIMED